CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 62 filers reported holding CUE BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $236,927 | -37.1% | 103,012 | -0.1% | 0.00% | – |
| Q2 2023 | $376,512 | +395.4% | 103,154 | +384.6% | 0.00% | – |
| Q1 2023 | $75,995 | +25.3% | 21,287 | 0.0% | 0.00% | – |
| Q4 2022 | $60,668 | +26.4% | 21,287 | -0.2% | 0.00% | – |
| Q3 2022 | $48,000 | -9.4% | 21,329 | -0.0% | 0.00% | – |
| Q2 2022 | $53,000 | -90.1% | 21,339 | -80.5% | 0.00% | – |
| Q1 2022 | $533,000 | -55.8% | 109,168 | +2.3% | 0.00% | – |
| Q4 2021 | $1,207,000 | -22.7% | 106,738 | -0.4% | 0.00% | – |
| Q3 2021 | $1,561,000 | +33.3% | 107,136 | +6.5% | 0.00% | – |
| Q2 2021 | $1,171,000 | -12.7% | 100,578 | -8.6% | 0.00% | – |
| Q1 2021 | $1,342,000 | -6.7% | 110,020 | -4.3% | 0.00% | – |
| Q4 2020 | $1,438,000 | -14.1% | 114,946 | +3.3% | 0.00% | – |
| Q3 2020 | $1,675,000 | -38.6% | 111,315 | -0.1% | 0.00% | -100.0% |
| Q2 2020 | $2,730,000 | +158.5% | 111,390 | +49.7% | 0.00% | – |
| Q1 2020 | $1,056,000 | +0.4% | 74,419 | +12.3% | 0.00% | – |
| Q4 2019 | $1,052,000 | +122.4% | 66,282 | +18.2% | 0.00% | – |
| Q3 2019 | $473,000 | -6.3% | 56,099 | -0.2% | 0.00% | – |
| Q2 2019 | $505,000 | +16.6% | 56,191 | +0.3% | 0.00% | – |
| Q1 2019 | $433,000 | +78.2% | 56,040 | +8.2% | 0.00% | – |
| Q4 2018 | $243,000 | -39.7% | 51,776 | +16.3% | 0.00% | – |
| Q3 2018 | $403,000 | -23.5% | 44,504 | -0.0% | 0.00% | – |
| Q2 2018 | $527,000 | +68.4% | 44,505 | +99.8% | 0.00% | – |
| Q1 2018 | $313,000 | – | 22,276 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 820,000 | $11,636,000 | 12.56% |
| Prosight Management, LP | 552,060 | $7,834,000 | 3.66% |
| Nantahala Capital Management | 2,503,840 | $35,529,000 | 1.33% |
| MANGROVE PARTNERS IM, LLC | 601,398 | $8,534,000 | 1.18% |
| Voss Capital, LLC | 88,670 | $749,000 | 1.00% |
| Slate Path Capital LP | 870,694 | $12,355,000 | 0.95% |
| Avoro Capital Advisors LLC | 1,870,000 | $26,535,000 | 0.90% |
| Bleichroeder LP | 165,000 | $2,341,000 | 0.61% |
| 683 Capital Management, LLC | 640,000 | $9,082,000 | 0.54% |
| PA Capital LLC | 40,706 | $578,000 | 0.51% |